多发性硬化症的疾病特征和认知障碍:短期观察是不够的
Bianka Suchá1, Pavel Šiarnik1, Stela Biathová1
11st Department of Neurology, Faculty of Medicine, Comenius University, Bratislava, Slovakia.
Neuro endocrinology letters
|December 31, 2024
概括
多发性硬化症 (MS) 的认知障碍与功能障碍有关,但与抑郁症或神经退行症标志物无关. 需要进一步的纵向研究来了解MS患者的这些关联.
科学领域:
- 神经科学是一个神经科学.
- 神经学 神经学
- 临床研究 临床研究
背景情况:
- 多发性硬化症 (MS) 是一种中枢神经系统疾病.
- 认知障碍 (CI) 是MS (pwMS) 患者的常见表现.
- CI显著影响 pwMS 的生活质量.
研究的目的:
- 调查MS认知障碍 (CI) 的性质.
- 探索pwMS中CI和疾病特征之间的关联.
- 为了确定MS群体中CI的预测因素.
主要方法:
- 使用符号数字模式测试和神经检查电池用于认知评估.
- 雇佣患者健康问卷-9用于抑郁症和扩展残疾状态尺度用于功能残疾.
- 评估了血神经丝光链 (pNfL) 作为神经退行症标志物.
主要成果:
- 在CI和非CI组之间认知功能和功能障碍的显著差异.
- 在抑郁症,pNfL水平或疾病修饰疗法类型方面没有发现显著差异.
- 数字跨度向前和跟踪制作测试-B独立预测了CI.
结论:
- 横截面设计没有确定CI与疾病特征或神经退行症标志物之间的关联.
- 长度研究是必要的,以阐明CI与MS疾病进展之间的关系.
- 进一步的前性研究是有必要的,以了解pwMS中的CI.
相关概念视频
Alzheimer's Disease: Overview
444
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
444
Language and Cognition
322
Language serves as a bridge between ideas and communication, influencing how individuals perceive and interact with the world. Psychologists have long debated whether language shapes thought or vice versa. This discussion gained grip with Edward Sapir and Benjamin Lee Whorf in the 1940s, who proposed that language determines thought, a concept known as linguistic determinism. They suggested that the vocabulary and structure of a language influence how its speakers think and perceive reality.
322
Negative and Cognitive Symptoms of Schizophrenia
43
Negative symptoms of schizophrenia indicate a reduction or absence of typical behaviors and emotional responses found in healthy individuals, while positive symptoms reflect an excess or distortion of normal functioning.
Negative Symptoms
Negative symptoms of schizophrenia manifest as deficits in normal emotional and behavioral functioning, profoundly impacting daily life. Individuals with schizophrenia often display a flat affect, characterized by a near-total absence of emotional expression,...
Negative Symptoms
Negative symptoms of schizophrenia manifest as deficits in normal emotional and behavioral functioning, profoundly impacting daily life. Individuals with schizophrenia often display a flat affect, characterized by a near-total absence of emotional expression,...
43
Parkinson's Disease: Overview
476
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
476
Dementia
94
Dementia is a collective term for cognitive disorders primarily affecting memory, thinking, and reasoning. It is not a specific disease but a syndrome, with Alzheimer's disease being the most common cause, accounting for approximately 60-80% of cases. Other types include vascular dementia, Lewy body dementia, and frontotemporal dementia. Dementia affects millions worldwide, particularly older adults, though it is not a normal part of aging.
The progression of dementia is generally gradual....
The progression of dementia is generally gradual....
94
Cognitive Enhancers: Cholinesterase Inhibitors and NMDA Receptor Antagonists
95
Cognitive enhancers, also known as "smart drugs," are substances used to enhance memory, mental alertness, and concentration. These can be natural or synthetic and improve cognition in conditions like Alzheimer's disease (AD) and other neurodegenerative diseases. Some common examples include caffeine, amphetamines, methylphenidate, modafinil, arecoline, donepezil, vortioxetine, and piracetam. These enhancers work on the principle of synaptic plasticity and altered circuit function.
95


